SUDEEP PHARMA Financial Statement Analysis
|
||
|
The Revenues of SUDEEP PHARMA have increased by 993.01% YoY .
The Earnings Per Share (EPS) of SUDEEP PHARMA has increased by 7.29 % YoY. |
||
SUDEEP PHARMA Last 5 Annual Financial Results
[BOM: 544619|NSE : SUDEEPPHRM]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹502 Cr | ₹46 Cr | ₹429 Cr | ₹3,430 Cr | ₹215 Cr |
| Expenses | ₹311 Cr | ₹28 Cr | ₹339 Cr | ₹2,756 Cr | ₹171 Cr |
| Operating Profit (Excl OI) | ₹191 Cr | ₹18 Cr | ₹90 Cr | ₹675 Cr | ₹44 Cr |
| Other Income | ₹9.33 Cr | ₹0.61 Cr | ₹9.52 Cr | ₹74 Cr | ₹3.44 Cr |
| Interest | ₹6.90 Cr | ₹0.47 Cr | ₹5.78 Cr | ₹17 Cr | ₹0.97 Cr |
| Depreciation | ₹11 Cr | ₹0.90 Cr | ₹7.92 Cr | ₹45 Cr | ₹3.53 Cr |
| Profit Before Tax | ₹183 Cr | ₹17 Cr | ₹86 Cr | ₹686 Cr | ₹43 Cr |
| Profit After Tax | ₹139 Cr | ₹13 Cr | ₹62 Cr | ₹502 Cr | ₹33 Cr |
| Consolidated Net Profit | ₹139 Cr | ₹13 Cr | ₹62 Cr | ₹502 Cr | ₹33 Cr |
| Earnings Per Share (Rs) | ₹15.31 | ₹14.27 | ₹945.26 | ₹442.31 | ₹356.01 |
| PAT Margin (%) | 26.64 | 26.48 | 29.00 | 14.54 | 14.63 |
| ROE(%) | 25.37 | 32.76 | 45.98 | 32.24 | 36.15 |
| ROCE(%) | 28.50 | 35.83 | 48.76 | 33.22 | 35.85 |
| Total Debt/Equity(x) | 0.17 | 0.27 | 0.21 | 0.37 | 0.51 |
Key Financials |
||
| Market Cap | : | ₹ 15,002.7 Cr |
| Revenue (TTM) | : | ₹ 675.6 Cr |
| Net Profit(TTM) | : | ₹ 183.6 Cr |
| EPS (TTM) | : | ₹ 16.3 |
| P/E (TTM) | : | 81.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SUDEEP PHARMA | 9.8% | 36.5% | NA |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -2.3% | 21.8% |
| DIVIS LABORATORIES | -1.6% | 9.8% | 51.8% |
| TORRENT PHARMACEUTICALS | -2.6% | -2.3% | 37.5% |
| CIPLA | -2.2% | -6.1% | -12.5% |
| DR REDDYS LABORATORIES | -0.9% | -1.8% | -9.8% |
| MANKIND PHARMA | -2.9% | -4.2% | -6.9% |
| LUPIN | -3.1% | -11.7% | 12.5% |
| ZYDUS LIFESCIENCES | -3.5% | 1.3% | 14.6% |
SUDEEP PHARMA Revenues
[BOM: 544619|NSE : SUDEEPPHRM]
| Y-o-Y | 993.01 % |
| 5 Yr CAGR | 23.60 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹502 Cr | 993.01 | |
| Mar2025 | ₹46 Cr | -89.29 | |
| Mar2024 | ₹429 Cr | -87.50 | |
| Mar2023 | ₹3,430 Cr | 1,494.61 | |
| Mar2022 | ₹215 Cr | - | |
SUDEEP PHARMA Operating Profit
[BOM: 544619|NSE : SUDEEPPHRM]
| Y-o-Y | 946.80 % |
| 5 Yr CAGR | 44.27 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹191 Cr | 946.80 | |
| Mar2025 | ₹18 Cr | -79.76 | |
| Mar2024 | ₹90 Cr | -86.63 | |
| Mar2023 | ₹675 Cr | 1,430.16 | |
| Mar2022 | ₹44 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -4.23 % |
| 5 Yr CAGR | 16.74 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 38.05% | -4.23 | |
| Mar2025 | 39.73% | 88.92 | |
| Mar2024 | 21.03% | 6.91 | |
| Mar2023 | 19.67% | -4.00 | |
| Mar2022 | 20.49% | - | |
SUDEEP PHARMA Profit After Tax
[BOM: 544619|NSE : SUDEEPPHRM]
| Y-o-Y | 941.59 % |
| 5 Yr CAGR | 42.82 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹139 Cr | 941.59 | |
| Mar2025 | ₹13 Cr | -78.63 | |
| Mar2024 | ₹62 Cr | -87.58 | |
| Mar2023 | ₹502 Cr | 1,404.62 | |
| Mar2022 | ₹33 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.60 % |
| 5 Yr CAGR | 16.16 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 26.64 % | 0.60 | |
| Mar2025 | 26.48 % | -8.69 | |
| Mar2024 | 29 % | 99.45 | |
| Mar2023 | 14.54 % | -0.62 | |
| Mar2022 | 14.63 % | - | |
SUDEEP PHARMA Earnings Per Share (EPS)
[BOM: 544619|NSE : SUDEEPPHRM]
| Y-o-Y | 7.29 % |
| 5 Yr CAGR | -54.46 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 | 7.29 | |
| Mar2025 | ₹14 | -98.49 | |
| Mar2024 | ₹945 | 113.71 | |
| Mar2023 | ₹442 | 24.24 | |
| Mar2022 | ₹356 | - | |
SUDEEP PHARMA Return on Capital Employed (ROCE)
[BOM: 544619|NSE : SUDEEPPHRM]
| Y-o-Y | -20.46 % |
| 5 Yr CAGR | -5.57 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 28.5% | -20.46 | |
| Mar2025 | 35.83% | -26.52 | |
| Mar2024 | 48.76% | 46.78 | |
| Mar2023 | 33.22% | -7.34 | |
| Mar2022 | 35.85% | - | |
SUDEEP PHARMA Share Price vs Sensex
| Current Share Price | : | ₹1,328.9 |
| Current MarketCap | : | ₹ 15,002.7 Cr |
| Updated EOD on | : | Sep 04,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 9.8% |
36.5% |
|
| SENSEX | -1% |
-2.6% |
-4.1% |
SUDEEP PHARMA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE IPO | 1% | 3.7% | 16% |
| BSE 1000 | -1% | -1.6% | 3.9% |
| BSE COMMODITIES | -1.1% | -1.6% | 13.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY IPO INDEX | 1.3% | 4.1% | 13.9% |
| NIFTY MICROCAP 250 | 0% | 2% | 15.1% |
| NIFTY SMALLCAP 500 | -0.1% | 1.2% | NA |
| NIFTY TOTAL MARKET | -1.1% | -1.9% | 4% |
You may also like the below Video Courses
FAQ about SUDEEP PHARMA Financials
How the annual revenues of SUDEEP PHARMA have changed ?
The Revenues of SUDEEP PHARMA have increased by 993.01% YoY .
How the Earnings per Share (EPS) of SUDEEP PHARMA have changed?
The Earnings Per Share (EPS) of SUDEEP PHARMA has increased by 7.29 % YoY .
Check out Intrinsic Value of Peers of SUDEEP PHARMA
Compare Stock Analytics of Peers of SUDEEP PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
